e-learning
resources
Madrid 2019
Monday, 30.09.2019
Phenotypes and endotypes of bronchiectasis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The effect of maintenance azithromycin on radiological features in patients with bronchiectasis
L. Terpstra (Alkmaar, Netherlands), J. Altenburg (Amsterdam, Netherlands), F. Mohamed Hoesein (Utrecht, Netherlands), P. De Jong (Utrecht, Netherlands), W. Boersma (Alkmaar, Netherlands)
Source:
International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Session:
Phenotypes and endotypes of bronchiectasis
Session type:
Thematic Poster
Number:
2865
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Terpstra (Alkmaar, Netherlands), J. Altenburg (Amsterdam, Netherlands), F. Mohamed Hoesein (Utrecht, Netherlands), P. De Jong (Utrecht, Netherlands), W. Boersma (Alkmaar, Netherlands). The effect of maintenance azithromycin on radiological features in patients with bronchiectasis. 2865
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
The bronchodilator response and clinical characteristics of patients with bronchiectasis
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019
Effects of long-term azithromycin treatment in patients with non-cystic fibrosis stable bronchiectasis
Source: Annual Congress 2007 - Infectious lung and pleural diseases
Year: 2007
The prevalence and clinical implications of bronchiectasis in patients with sarcoidosis
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019
Inter-observer variability in CT evaluation of effect of azithromycin therapy in non-cystic fibrosis bronchiectatic patients
Source: Annual Congress 2010 - Infection, inflammation and destruction
Year: 2010
The relationship between radiological severity and clinical phenotype in bronchiectasis
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019
Long-term treatment with low-dose azithromycin reduces cough, sputum production and exacerbations in patients with idiopathic diffuse bronchiectasis
Source: Eur Respir J 2004; 24: Suppl. 48, 707s
Year: 2004
Effects of exacerbation risk on symptoms and clinical characteristics in patients with bronchiectasis
Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation
Year: 2012
The radiographic bronchiectasis in patients with COPD-OSA overlap syndrome
Source: International Congress 2019 – Bronchiectasis
Year: 2019
Our clinical experience in surgical therapy of patients with bronchiectasis
Source: Eur Respir J 2002; 20: Suppl. 38, 344s
Year: 2002
Usefulness of long term treatment with azithromycin in patients with bronchiectasis (non cystic fibrosis)
Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections
Year: 2010
Demographics and characteristics of antibiotic use in non-cystic fibrosis bronchiectasis patients
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016
Effectiveness of corticosteroids on HRCT features of COVID 19 pneumonia
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Year: 2021
HRCT features do not predict the clinical course in children with protracted bacterial bronchitis
Source: Annual Congress 2012 - Paediatric bronchology
Year: 2012
A broad immunological screening may impact treatment in bronchiectasis patients
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019
The effect of long term low dose azithromycin on symptoms and lung function in pulmonary sarcoidosis
Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity
Year: 2008
Effect of azithromycin treatment on inflammation in COPD patients
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019
Comparing clinical features of cases with bronchiectasis on acute and stable term
Source: Eur Respir J 2005; 26: Suppl. 49, 305s
Year: 2005
Prevalence, features of the course and treatment efficacy airway obstruction in patients with newly diagnosed pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: clinical findings I
Year: 2012
The features of patients with sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 436s
Year: 2002
Explorative analyses of inflammatory pathways and the effect of azithromycin in bronchiectasis patients
Source: International Congress 2019 – Bronchiectasis
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept